Y108D (p.Tyr108Asp) variant of INS (Insulin)
Y108D (p.Tyr108Asp) in INS (Insulin) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as likely pathogenic in the context of Neonatal diabetes mellitus. The available variant effect predictions contribute to a CATVariant prioritization score of 0.85 / 1. The record also includes structural context.
Y108D (p.Tyr108Asp) variant details
- p.Tyr108Asp
- rs2133672778
- ClinGen CA379120673
- ClinVar RCV002052030
- Ensembl rs2133672778
- Likely pathogenic
- Neonatal diabetes mellitus
- Missense
- Variant Prioritization Score for Impact Estimate 0.846
- REVEL 0.96
- ESM-1b 1.00
- AlphaMissense 0.99
- MetaLR 0.92
- MetaSVM 1.03
- CADD 28.60
- ClinVar: Likely pathogenic (Neonatal diabetes mellitus)
- EBI: Likely pathogenic (in PNDM4)
- UniProt: Likely pathogenic (in PNDM4)
- Structural context available